These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 29659337)

  • 1. Hyperandrogenic athletes: performance differences in elite-standard 200m and 800m finals.
    Ospina Betancurt J; Zakynthinaki MS; Martinez-Patiño MJ; Cordente Martinez C
    J Sports Sci; 2018 Nov; 36(21):2464-2471. PubMed ID: 29659337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outstanding performances during elite-standard short and middle-distance finals and the hyperandrogenism regulation-A detailed analysis of Caster Semenya's results.
    Ospina-Betancurt J; Zakynthinaki MS
    J Sports Sci; 2020 Mar; 38(6):703-709. PubMed ID: 32050847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethics of Regulating Competition for Women with Hyperandrogenism.
    Camporesi S
    Clin Sports Med; 2016 Apr; 35(2):293-301. PubMed ID: 26832978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex-differences in elite-performance track and field competition from 1983 to 2015.
    Ospina Betancurt J; Zakynthinaki MS; Martínes-Patiño MJ; Cordente Martinez C; Rodríguez Fernández C
    J Sports Sci; 2018 Jun; 36(11):1262-1268. PubMed ID: 28862921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. When does an advantage become unfair? Empirical and normative concerns in Semenya's case.
    Camporesi S
    J Med Ethics; 2019 Nov; 45(11):700-704. PubMed ID: 31527141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A question of 'fairness': Why ethics should factor in the Court of Arbitration for Sport's decision on the IAAF Hyperandrogenism Regulations.
    Camporesi S
    Br J Sports Med; 2019 Jul; 53(13):797-798. PubMed ID: 29643090
    [No Abstract]   [Full Text] [Related]  

  • 7. The End of Compulsory Gender Verification: Is It Progress for Inclusion of Women in Sports?
    Ospina-Betancurt J; Vilain E; Martinez-Patiño MJ
    Arch Sex Behav; 2021 Oct; 50(7):2799-2807. PubMed ID: 34494166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Policing the boundaries of sex: a critical examination of gender verification and the Caster Semenya controversy.
    Cooky C; Dworkin SL
    J Sex Res; 2013; 50(2):103-11. PubMed ID: 23320629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caster Semenya, athlete classification, and fair equality of opportunity in sport.
    Loland S
    J Med Ethics; 2020 Sep; 46(9):584-590. PubMed ID: 32690761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The new policy on hyperandrogenism in elite female athletes is not about "sex testing".
    Sánchez FJ; Martínez-Patiño MJ; Vilain E
    J Sex Res; 2013; 50(2):112-5. PubMed ID: 23320653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are the World Junior Championship Finalists for Middle- and Long-Distance Events Currently Competing at International Level?
    Pizzuto F; Bonato M; Vernillo G; La Torre A; Piacentini MF
    Int J Sports Physiol Perform; 2017 Mar; 12(3):316-321. PubMed ID: 27294320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Women with hyperandrogenism in elite sports: scientific and ethical rationales for regulating.
    Bermon S; Vilain E; Fénichel P; Ritzén M
    J Clin Endocrinol Metab; 2015 Mar; 100(3):828-30. PubMed ID: 25587809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Of Athletes, Bodies, and Rules: Making Sense of
    Winkler M; Gilleri G
    J Law Med Ethics; 2021; 49(4):644-660. PubMed ID: 35006046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administering drugs to an individual in a non-pathological situation: The Caster Semenya case.
    Jagadeesh N
    Indian J Med Ethics; 2020; V(2):139-143. PubMed ID: 32393456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful Pacing Profiles of Olympic and IAAF World Championship Middle-Distance Runners Across Qualifying Rounds and Finals.
    Hanley B; Stellingwerff T; Hettinga FJ
    Int J Sports Physiol Perform; 2019 Jul; 14(7):894-901. PubMed ID: 30569794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal Eligibility Criteria for 'Includes Females' Competition: A Practical but Problematic Solution.
    Allen DB
    Horm Res Paediatr; 2016; 85(4):278-82. PubMed ID: 26872015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Better water jump clearances were differentiated by longer landing distances in the 2017 IAAF World Championship 3000 m steeplechase finals.
    Hanley B; Bissas A; Merlino S
    J Sports Sci; 2020 Feb; 38(3):330-335. PubMed ID: 31774365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peak Age and Performance Progression in World-Class Track-and-Field Athletes.
    Haugen TA; Solberg PA; Foster C; Morán-Navarro R; Breitschädel F; Hopkins WG
    Int J Sports Physiol Perform; 2018 Oct; 13(9):1122-1129. PubMed ID: 29543080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Interconnected Histories of Endocrinology and Eligibility in Women's Sport.
    Rogol AD; Pieper LP
    Horm Res Paediatr; 2018; 90(4):213-220. PubMed ID: 30336491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Elevated Track in Pole Vault: An Advantage During Run-Up?
    Cassirame J; Sanchez H; Morin JB
    Int J Sports Physiol Perform; 2018 Jul; 13(6):717-723. PubMed ID: 29035596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.